Wilson Sonsini Goodrich & Rosati advised Verve Therapeutics on IP matters related to the transaction.Verve Therapeutics, Inc. (Nasdaq:VERV) announced the expansion of its relationship with Eli Lilly and…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
